๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

0605 Inosine in the treatment of multiple sclerosis: an open-label study in 32 patients

Book ID
119467148
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
253 KB
Volume
238
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Oral fumaric acid esters for the treatme
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study
โœ S. Schimrigk; N. Brune; K. Hellwig; C. Lukas; B. Bellenberg; M. Rieks; V. Hoffma ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB

An exploratory, prospective, openโ€label study of fumaric acid esters (FAE, Fumadermยฎ) was conducted in patients with relapsingโ€“remitting multiple sclerosis (RRMS). The study consisted of the following four phases: 6โ€week baseline, 18โ€week treatment (target dose of 720โ€ƒmg/day), 4โ€week washout, and a

Paroxetine in the treatment of depressed
Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study
โœ Chi-Un Pae; Yoo-Jin Kim; Wang-Youn Won; Hee-Je Kim; Seok Lee; Chang-Uk Lee; Soo- ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB ๐Ÿ‘ 2 views

## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a